Carmignac Gestion »

Catalyst Pharmaceutical Partners shares owned by Carmignac Gestion

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Carmignac Gestion from 13F filings

Historical chart of Carmignac Gestion investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Carmignac Gestion consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Carmignac Gestion

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.0M 96k 31.43

More positions owned by Carmignac Gestion

NVIDIA Corporation (NVDA)
Broadcom (AVGO)
AmerisourceBergen (COR)
McKesson Corporation (MCK)
Alphabet Cap Stk Cl A (GOOGL)
Tradeweb Markets Cl A (TW)
Mastercard Cl A (MA)
S&p Global (SPGI)
Berkshire Hathaway CL B (BRK.B)
MercadoLibre (MELI)
Intercontinental Exchange (ICE)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Amphenol Corp Cl A (APH)
Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH)

View all positions for Carmignac Gestion

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
State Street Corporation
American Century Companies
Vanguard Capital Management
Dimensional Fund Advisors
Glazer Capital
Jpmorgan Chase & Co
Geode Capital Management
HBK Investments
Morgan Stanley
Vanguard Portfolio Management
Jupiter Topco
Qube Research & Technologies
Renaissance Technologies
Henderson Group

View all funds holding Catalyst Pharmaceutical Partners